Janus Kinase (JAK) Inhibitors (IC50, Ki)
Structure ▲ ▼ | Compound Name ▲ ▼ | Standard Type ▲ ▼ | Standard Values (in nM) ▲ ▼ |
Ruxolitinib | IC50 | 100.0 [1] | |
CID 53344620 | IC50 | 27.0 [1] | |
[2-[6-(2-Ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl]-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-(5-piperidin-1-ylpyrazin-2-yl)methanone | IC50 | 70.3 [1] | |
4-[3-(1h-Benzimidazol-2-Yl)-1h-Indazol-6-Yl]-3-Ethylphenol | IC50 | 10.5 [1] | |
6-(2-Ethyl-4-Hydroxyphenyl)-1h-Indazole-3-Carboxamide | IC50 | 19.1 [1] | |
6-(2-Ethyl-4-Hydroxyphenyl)-N-(6-Methylpyridin-3-Yl)-1h-Indazole-3-Carboxamide | IC50 | 277.8 [1] | |
6-(2-Methoxy-4-hydroxyphenyl)-3-1H-benzoimidazol-2-yl-1H-indazole | IC50 | 57.8 [1] | |
3-1H-Benzoimidazol-2-yl-6-(3-hydroxyphenyl)-1H-indazole | IC50 | 572.7 [1] | |
[2-[6-(2-Ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl]-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-(4-fluorophenyl)methanone | IC50 | 35.0 [1] | |
4-[3-(5-Benzyl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl]-5-ethyl-2-fluorophenol | IC50 | 30.4 [1] |
References
This online tool may be cited as follows
MLA | "Quest Database™ Janus Kinase (JAK) Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/janus-kinase-jak-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2024, November 21). Quest Database™ Janus Kinase (JAK) Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/janus-kinase-jak-inhibitors-ic50-ki. | |
BibTeX | EndNote | RefMan |